FindTrial
Sign In

Characterization of the clinical sensory phenotype in lipedema patients

Characterization of the clinical sensory phenotype in lipedema patients - Cause of lipedema pain

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00030509
Enrollment
40
Registered
2022-10-19
Start date
2021-11-09
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E88.28

Interventions

Group 1: Observational study: Assessment of the sensory profile of lipedema patients by quantitative sensory testing according to the protocol of the DFNS Group 2: Observational study: Assessment of t

Sponsors

Universitätsklinikum Köln
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: (diagnosis: lipohyperplasia dolorosa) BMI < 30 kg/m2 waist < 80 cm

Exclusion criteria

Exclusion criteria: restrains in communication skills, diseases that affect the sensory nervous system, skin irritations at the testing area, topical application of analgesics at the testing ares, alterations in pain perception or diagnosis of chronic pain

Design outcomes

Primary

MeasureTime frame
Characterization of alterations in sensory modalities in lipedema patients. Assessment of a full QST profile according to the protocol of the DFNS.—

Secondary

MeasureTime frame
parameters of the German Pain Questionnaire—

Countries

Germany

Contacts

Public ContactRebecca Dinnendahl

Translationale SchmerzforschungKlinik für Anästhesiologie und Operative IntensivmedizinUniversitätsklinikum Köln (AöR)

rebecca.dinnendahl@uk-koeln.de0221/478-42784

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026